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Abstract
Retinoic acid (RA) produced by intestinal dendritic cells (DCs) imprints gut-homing speciﬁcity on
lymphocytes and enhances Foxp3
1 regulatory T-cell differentiation. The expression of aldehyde
dehydrogenase (ALDH) 1A in these DCs is essential for the RA production. However, it remains
unclear how the steady-state ALDH1A expression is induced under speciﬁc pathogen-free (SPF)
conditions. Here, we found that bone marrow-derived dendritic cells (BM-DCs) generated with
granulocyte-macrophage colony-stimulating factor (GM-CSF) expressed Aldh1a2, an isoform of
Aldh1a, but that fms-related tyrosine kinase 3 ligand-generated BM-DCs did not. DCs from mesenteric
lymph nodes (MLN) and Peyer’s patches (PP) of normal SPF mice expressed ALDH1A2, but not the
other known RA-producing enzymes. Employing a ﬂow cytometric method, we detected ALDH
activities in 10–30% of PP-DCs and MLN-DCs. They were CD11c
highCD4
2/lowCD8a
intermediateCD11b
2/low
F4/80
low/intermediateCD45RB
lowCD86
highMHC class II
highB220
2CD103
1. Equivalent levels of aldehyde
dehydrogenase activity (ALDHact) and ALDH1A2 expression were induced synergistically by GM-CSF
and IL-4 in splenic DCs in vitro. In BM-DCs, however, additional signals via Toll-like receptors or RA
receptors were required for inducing the equivalent levels. The generated ALDH1A2
1 DCs triggered
T cells to express gut-homing receptors or Foxp3. GM-CSF receptor-deﬁcient or vitamin A-deﬁcient
mice exhibited marked reductions in the ALDHact in intestinal DCs and the T cell number in the
intestinal lamina propria, whereas IL-4 receptor-mediated signals were dispensable. GM-CSF
1
CD11c
2F4/80
1 cells existed constitutively in the intestinal tissues. The results suggest that GM-CSF
and RA itself are pivotal among multiple microenvironment factors that enable intestinal DCs to
produce RA.
Introduction
The vitamin A metabolite retinoic acid (RA) plays critical
roles in gut immunity. We found that RA is produced by den-
dritic cells (DCs) in the gut-associated lymphoid organs,
Peyer’s patches (PP) and mesenteric lymph nodes (MLN),
and imprints gut-homing speciﬁcity on T cells upon antigenic
stimulation (1). Indeed, vitamin A-deﬁcient mice exhibited
depletion of T cells in the small intestinal tissues (1). RA also
imprints B cells with gut-homing speciﬁcity and contributes
to their IgA production (2). Recently, it was found that RA
enhances the transforming growth factor (TGF)-b-dependent
differentiation of naive T cells into Foxp3
+ regulatory T cells
(Treg) (3–10), but suppresses the differentiation of Th17 cells
that contribute to inﬂammation (3, 7, 8, 10), and may contribute
to oral tolerance. Therefore, RA appears to be a key molecule
that controls lymphocyte trafﬁcking and immune responses.
However, it remains poorly understood how intestinal DCs ac-
quire the RA-producing capacity.
The major pathway of RA synthesis depends on two steps
(11, 12). The ﬁrst step from vitamin A (retinol) to retinalde-
hyde is catalyzed by a subfamily of alcohol dehydrogenases
that are expressed in most cells including DCs (1) or by the
short-chain dehydrogenase/reductase family (13, 14). The
second step from retinaldehyde to RA is catalyzed by alde-
hyde dehydrogenase (ALDH) 1A [retinal dehydrogenase
(RALDH)], a subfamily of ALDH. ALDH1A expression is
limited to certain cell types and is thus a key to the
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express Aldh1a or ALDH1A, whereas DCs in the spleen
(SPL) or peripheral lymph nodes (PLN) that drain skin barely
express it (1). DCs in the lamina propria (LP) of the small in-
testine also express Aldh1a (15). Here, we obtained a ﬂow
cytometric method to estimate aldehyde dehydrogenase ac-
tivity (ALDHact) in individual DCs by modifying a detection
system for hematopoietic stem cells (16) and identiﬁed the
DC subsets with ALDHact
+ in MLN and PP. DCs are likely to
start expressing ALDH1A after they immigrated into the gut
since DCs are plastic in nature (17) and can be re-
programmed by tissue microenvironment to instruct T cells
with other homing speciﬁcity (18). Thus, the microenviron-
ment of the gut, even without active immunization or patho-
genic bacterial infection, might speciﬁcally induce ALDH1A
expression in DCs. RA itself has been previously implicated to
endow swine monocyte-derived DCs with some attributes of
gut DCs (19). Here, we found that granulocyte-macrophage
colony-stimulating factor (GM-CSF) as well as vitamin A
appears to play important roles in the differentiation of
ALDH1A-expressing intestinal DCs in vivo. The expression of
the major ALDH1A isoform, ALDH1A2 (RALDH2), was syner-
gistically and strongly induced in DCs by GM-CSF and IL-4 in
vitro and was further enhanced by Toll-like receptor (TLR)
ligands and RA itself, but was only weakly induced by RA
alone. The present study also suggests that DCs generated
with GM-CSF possess the capacity to produce RA and gradu-
ally lose it in culture without GM-CSF.
Materials and methods
Mice
B10.D2 mice were from Japan SLC (Shizuoka, Japan).
C57BL/6 and BALB/c mice were from CLEA Japan (Tokyo,
Japan). TCR-DO11.10/Rag2
/ (B10.D2 background) and
a chain of IL-4 receptor-deﬁcient (IL-4Ra
/; BALB/c back-
ground) mice were from Taconic Farms (Hudson, NY, USA).
Common b subunit of GM-CSF/IL-3/IL-5 receptor-deﬁcient
(Beta-c
/; C57BL/6 background) mice were from the Jack-
son Laboratory (Bar Harbor, ME, USA). Vitamin A-deﬁcient
mice were produced as described previously (1) with a mod-
iﬁcation; control diet contained 5000 IU/kg of retinyl acetate.
All animals were maintained in speciﬁc pathogen-free (SPF)
conditions in our animal facility. All animal experiments were
performed according to the protocols approved by the Ani-
mal Care and Use Committee of Tokushima Bunri University.
Reagents
Recombinant murine GM-CSF, fms-like tyrosine kinase 3
ligand (Flt3L), IL-23, IFN-a, IFN-b, thymic stromal lympho-
poietin (TSLP) and CX3CL1 were from R&D Systems (Minne-
apolis, MN, USA). Recombinant murine IL-2, IL-3, IL-4, IL-5,
IL-6, IL-10, IL-12, IL-13, IFN-c, tumor necrosis factor (TNF)-a
and human TGF-b1 and TGF-b2 were from Peprotech
(Rocky Hill, NJ, USA). Rosiglitazone was from Alexis Bio-
chemicals (Lausanne, Switzerland). TO901317 was from
Cayman Chemicals (Ann Arbor, MI, USA). Prostaglandin E2
and leukotriene B4 were from Biomol International (Plymouth
Meeting, PA, USA). Soluble sonicated peptidoglycan (sPGN;
from Escherichia coli K12), poly(I:C), R837 and immunosti-
mulatory oligodeoxynucleotides containing unmethylated
cytosine-phosphate-guanosine (CpG ODN) 1826 were from
InvivoGen (San Diego, CA, USA). LPS (from E. coli O55:B5)
and all-trans-RA were from Sigma–Aldrich (St Louis, MO,
USA). LE540 was a kind gift from Dr Hiroyuki Kagechika
(Tokyo Medical and Dental University, Tokyo, Japan). A list
of mAbs that were used for cell isolation and staining is pro-
vided as Supplementary Table 1 (available at International
Immunology Online).
Isolation of DCs and CD11c
F4/80
+ cells
PP were treated with complete medium (Dulbecco’s modi-
ﬁed essential medium supplemented with 100 lM non-
essential amino acids, 2 mM L-glutamine, 1 mM sodium
pyruvate, 50 lM 2-mercaptoethanol, 25 mM HEPES, 100 U
ml
1 penicillin, 100 lgm l
1 streptomycin and 10% FCS)
containing 5 mM EDTA and 1 mM dithiothreitol for 15 min at
37 C to remove intestinal epithelial cells (IECs). PP, MLN,
PLN and SPL were digested with 400 Mandl U ml
1 collage-
nase type I (Sigma–Aldrich) and 30 U ml
1 DNase I (Invitro-
gen, Carlsbad, CA, USA) in complete medium with
continuous stirring for 45–90 min at 37 C. For isolation of
DCs, cells were incubated with anti-CD11c microbeads and
then immunomagnetically sorted by sequential passage over
2 MACS separation columns (Miltenyi Biotec, Bergisch Glad-
bach, Germany), resulting in >96% purity. For sorting of DCs
into CD103
+ and CD103
 subsets, cells were incubated with
allophycocyanin (APC)-conjugated anti-CD11c and PE-con-
jugated anti-CD103 mAbs, followed by anti-APC microbeads.
For sorting of CD11c
F4/80
+ cells, cells were incubated with
APC-conjugated anti-CD11c and PE-conjugated F4/80
mAbs, followed by anti-APC and anti-PE microbeads. Cells
were ﬁrst enriched by immunomagnetic cell sorting on a
MACS separation column. Positively selected cells were
sorted on a FACSAria (BD Biosciences, Franklin Lakes, NJ,
USA), to >95% purity.
Isolation of IECs and LP lymphocytes
The jejunum and ileum were dissected and were ﬂushed
with HBSS without Ca
2+ and Mg
2+ to remove fecal contents.
The intestinal segments were incubated with HBSS contain-
ing 1 mM dithiothreitol for 15 min at 37 C. The cell suspen-
sions were ﬁltered through cell strainers. The recovered
cells were washed twice with HBSS and were used as IECs.
For isolation of LP lymphocytes, the fragments of small intes-
tine were shaken three times in EDTA and dithiothreitol in
HBSS supplemented with 10 mM HEPES, 50 lgm l
1 genta-
micin, 2.5 lgm l
1 fungizone, 10% FCS for 20 min at 37 C,
cut into smaller pieces and then digested with collagenase
and DNase in complete medium for 1 h at 37 C. The cell
suspensions were ﬁltered, washed, re-suspended in 40%
isotonic Percoll (GE Healthcare, Little Chalfont, UK), layered
onto 75% isotonic Percoll and centrifuged at 1000 3 g for
20 min at room temperature. LP lymphocytes were collected
at the interface of the Percoll gradient.
Immunoblotting
Rabbit anti-mouse ALDH1A2 antibodies were generated by
immunizing the peptide CGGKGLGRKGFFIEP and were
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NaCl, 20 mM Tris–HCl, 1 mM EDTA and 1% protease inhibitor
cocktail (Nacalai Tesque, Kyoto, Japan) were centrifugated at
20000 3 g for 5 min. Proteins in the supernatants were sepa-
rated by SDS–PAGE, transferred to nitrocellulose membranes
(GE Healthcare), probed with anti-ALDH1A2 antibody and
HRP-conjugated goat anti-rabbit IgG antibody (Zymed Labo-
ratories, South San Francisco, CA, USA) and developed by
ECL Western Blotting Detection Reagents (GE Healthcare).
Densitometric analysis was performed on a LAS-3000 (Fujiﬁlm,
Tokyo, Japan). The signal intensity of treated cells was
expressed as the fold induction relative to that of untreated cells.
Real-time PCR
Total RNA was isolated from cells using RNeasy Micro Kit,
and cDNA was generated using QuantiTect Reverse Tran-
scription Kit (both from Qiagen, Hilden, Germany). cDNA
was used as a template for real-time PCR in triplicates with
Power SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA, USA) and gene-speciﬁc primers (Supple-
mentary Table 2 is available at International Immunology
Online). PCR and analysis were performed on an Applied
Biosystems 7500 Real-time PCR system. The expression of
each gene was normalized with Rplp0.
Flow cytometric analysis
Cells were stained with ﬂuorochrome-conjugated mAbs
(Supplementary Table 1 is available at International Immu-
nology Online) in the presence of anti-CD16/CD32 mAb.
Some cells were stained with mouse E-selectin/human IgG
Fc chimera (R&D Systems) and PE-conjugated goat anti-
human IgG-Fc antibody (Jackson ImmunoResearch, West
Grove, PA, USA). For staining of IgA
+ B cells, cells were
stained with biotinylated goat anti-mouse IgA antibody
(Southern Biotechnology Associates, Inc., Birmingham, AL,
USA) and PE-conjugated anti-B220 mAb, followed by APC-
conjugated streptavidin (eBioscience, San Diego, CA, USA).
To exclude dying cells, 1 ng ml
1 of propidium iodide
(Sigma–Aldrich) was added. Intracellular staining of Foxp3
was performed using APC mouse/rat Foxp3 staining sets
(eBioscience). For intracellular cytokine staining, cells
obtained from cultures or isolated LP lymphocytes were
stimulated for 5 h with 50 ng ml
1 phorbol 12-myristate 13-
acetate and 750 ng ml
1 ionomycin (both from Calbiochem,
Darmstadt, Germany). Monensin (3 lM; Sigma–Aldrich) was
added to the cultures during the last 2 h. After surface stain-
ing, the cells were ﬁxed and permeabilized with IC Fixation/
Permeabilization Buffers (eBioscience), and intracellular cy-
tokine staining was performed according to the manufac-
turer’s protocol. Analysis was performed on a FACSAria,
FACSCanto or FACSCalibur ﬂow cytometer (all from BD
Biosciences). In some experiments, expression levels were
expressed as Dmean ﬂuorescence intensity (MFI) which
was calculated as: (MFI of the cells stained with
ﬂuorochrome-conjugated antibody)  (MFI of the background
staining cells).
Analysis of ALDHact
ALDHact in individual cells was estimated using ALDE-
FLUOR staining kits (StemCell Technologies, Vancouver, British
Columbia, Canada), according to the manufacturer’s protocol
with modiﬁcations. Brieﬂy, cells suspended at 10
6 cells ml
1
in ALDEFLUOR assay buffer containing activated ALDE-
FLUOR substrate (150 nM) with or without the ALDH
inhibitor diethylaminobenzaldehyde (DEAB; 100 lM; Sigma–
Aldrich) were incubated for 30 min at 37 C. For immuno-
phenotyping of ALDEFLUOR-reacted cells, the cells were
subsequently stained with PE-, PE-Cy7- or APC-conjugated
mAbs in ice-cold ALDEFLUOR assay buffer. ALDEFLUOR-
reacted cells were detected using a FACSAria, FACSCanto
or FACSCalibur ﬂow cytometer with 488-nm blue laser and
standard FITC 530/30 nm bandpass ﬁlter. Cell viability was
determined by ﬂow cytometry with propidium iodide exclu-
sion, and the viability of DCs was not affected by exposure
to ALDEFLUOR.
Immunohistochemical analysis
CD4
+ or CD8
+ cells were immunostained as previously de-
scribed using frozen tissue sections and TO-PRO-3 (Molecu-
lar Probes, Eugene, OR, USA) for nuclear staining (1). For
double immunostaining for GM-CSF and CD11c or F4/80,
sections were blocked with 5% normal donkey serum for
1 h at room temperature and incubated with anti-GM-CSF
mAb for 48 h at 4 C, followed by Cy3-conjugated anti-rat
IgG antibody (Jackson ImmunoResearch) for 1 h at room
temperature. The sections were blocked with Avidin D/biotin
solutions (Vector Laboratories, Burlingame, CA, USA) and
then incubated with biotinylated anti-CD11c or anti-F4/80
mAb at 4 C overnight, followed by FITC-conjugated strepta-
vidin (Jackson ImmunoResearch) for 1 h at room tempera-
ture. Immunostained sections were coverslipped with
glycerol and observed using a confocal laser scanning
microscopy (FV1000, Olympus, Tokyo, Japan).
Culture of DCs
Bone marrow (BM) progenitors were harvested from femurs
and tibias of B10.D2 mice and were immunomagnetically
sorted by negative selection using PE-conjugated mAbs to
B220, CD49b, Gr-1, I-A
d, TER-119 and Thy1.2 followed by
anti-PE microbeads. Bone marrow-derived dendritic cells
(BM-DCs) were generated with 20 ng ml
1 GM-CSF or
20 ng ml
1 Flt3L for 8 days, as described previously (20,
21). The purity of CD11c
+ cells generated from GM-CSF- or
Flt3L-supplemented BM cultures routinely exceed 87 or
95%, respectively. For treatment with various reagents,
Flt3L-induced BM-DCs (2 3 10
5 cells) were cultured in
200 ll of complete medium containing indicated reagents in
a well of ﬂat-bottomed 96-well plates for 48 h. SPL-DCs were
cultured under the same conditions but for 24 h.
DC-T cell co-cultures
Naive CD4
+CD62L
high T cells were puriﬁed from splenocytes
as previously described (22). DCs were pulsed with ovalbu-
min (OVA) peptide P323-339 (1 lM) for 2 h and then co-
cultured with naive CD4
+ T cells (4 3 10
4 cells) obtained from
TCR-DO11.10/Rag2
/ mice at a ratio of 1:5 (DCs:T cells) in
200 ll of complete medium in a well of round-bottomed 96-
well plates for 5 days. For Treg differentiation, DCs (4 3 10
3
cells) were co-cultured with naive CD4
+ T cells (4 3 10
4
cells) in the presence of OVA peptide P323-339 (1 lM),
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1 TGF-b1 and 100 U ml
1 IL-2 for 3 days. For Th17
differentiation, 20 ng ml
1 IL-6 and 20 ng ml
1 IL-23 were
also included in the culture. Treg or Th17 cultures were sup-
plemented with IL-2 and incubated for an additional 2 days.
Alternatively, freshly isolated MLN-DCs (1 3 10
4 cells)
obtained from Beta-c
/ or wild-type (wt) mice were co-
cultured with naive CD4
+ T cells (5 3 10
4 cells) obtained
from wt mice and soluble anti-CD3e mAb (1 lgm l
1) for
5 days. In some cultures, DEAB was added at a ﬁnal con-
centration of 100 lM.
Statistics
Statistical comparisons were performed using the one-way
analysis of variance with Tukey–Kramer multiple compari-
sons test and the two-tailed unpaired Student’s t test. Values
<0.05 were considered statistically signiﬁcant.
Results
A subset of CD103
+ mature DCs in MLN and PP expresses
ALDH1A2
We have previously found that MLN-DCs express Aldh1a2
(1). The expression of ALDH1A2 protein in MLN-DCs was
conﬁrmed with speciﬁc antibodies (Fig. 1A). PP-DCs also
expressed Aldh1a2 but to a much lesser extent than MLN-
DCs, whereas CD11c
 cells in MLN or PP did not signiﬁ-
cantly express it (Fig. 1B). Expression of Aldh1a1 (encoding
RALDH1), Aldh1a3 (encoding RALDH3), Aldh8a1 (encoding
RALDH4), Cyp1b1 or Cyp2j6 (the orthologous gene of rat
Cyp2j4) was not signiﬁcantly detected in DCs or CD11c

cells from MLN, PP or SPL of B10.D2 mice that were kept
under SPF conditions (Fig. 1B). CYP1B1 and CYP2J6 are
ALDH1A-independent RA-producing enzymes (23, 24). It
was reported that CD103
+ MLN-DCs expressed Aldh1a2
(4). Similarly, CD103
+ PP-DCs but not CD103
 PP-DCs
expressed Aldh1a2 (Fig. 1C).
Since ALDH1A constitute a subfamily of ALDH, we mea-
sured the relative ALDHact in individual cells by ﬂow cytom-
etry with a ﬂuorescent substrate for ALDH. Among MLN
cells, ALDHact was detected almost exclusively in CD11c
+
cells (Fig. 1D). The proportion of the cells with high ALDHact
(ALDHact
high) in MLN-DCs was much larger than that in PP-
DCs (Fig. 1E). The ALDHact was inhibited by the ALDH in-
hibitor DEAB. These results collectively suggest that
ALDH1A2 is almost solely responsible for producing RA in
MLN-DCs and PP-DCs in SPF mice. Furthermore, in MLN,
ALDHact was exclusively exhibited by CD11c
highCD4
/low
CD8a
intermediateCD11b
/lowF4/80
low/intermediateCD45RB
lowCD86
high
MHC class II
highB220
CD103
+ DCs (Fig. 1F). We also esti-
mated ALDHact in speciﬁc subsets of MLN-DCs divided
according to the expression levels of CD8a and CD103. The
CD8a
intermediateCD103
high subset exhibited high ALDH
activities, and the CD8a
CD103
intermediate and CD8a
high
CD103
intermediate subsets exhibited intermediate and low ALDH
activities, respectively, whereas the CD103
 subsets failed to
exhibit the activity (Supplementary Figure 1A is available at In-
ternational Immunology Online). The Aldh1a2 expression was
in good accord with the activity (Supplementary Figure 1B is
available at International Immunology Online). The phenotype
of ALDHact
high cells in PP-DCs was similar to that in MLN-DCs
(data not shown). SPL-DCs contained few ALDHact
+ cells,
whereas PLN-DCs consistently contained a small number of
ALDHact
+ cells, some of which were ALDHact
high cells (data
not shown).
GM-CSF, IL-4 and IL-13 induce ALDH1A2 expression in DCs
To identify the factors that induce ALDH1A2 expression in
DCs, we prepared BM-DCs with GM-CSF or Flt3L. Unex-
pectedly, we found that GM-CSF-induced BM-DCs
expressed Aldh1a2, although an extended culture in new
plates without GM-CSF resulted in a gradual loss of the
Aldh1a2 expression after a transient recovery in the expres-
sion (Supplementary Figure 2 is available at International
Immunology Online). The extended culture with or without
GM-CSF rapidly triggered the cells to spread and attach to
the new culture plates, and it might induce some signals for
the transient increase in the expression. On the other hand,
Flt3L-induced BM-DCs did not express Aldh1a2 (Fig. 2A).
To conﬁrm the ability of GM-CSF to induce Aldh1a2 expres-
sion, we cultured Flt3L-induced BM-DCs with GM-CSF for
48 h and found that GM-CSF indeed triggered them to ex-
press Aldh1a2 (Fig. 2B). Unless otherwise indicated, we
describe Flt3L-induced BM-DCs as simply BM-DCs hence-
forth. In SPL-DCs, GM-CSF also induced Aldh1a2 expression
(Fig. 2B).
We then examined if other cytokines and factors available
in the intestine could also trigger Aldh1a2 expression in BM-
DCs. Two days of culture with IL-4 or IL-13 signiﬁcantly in-
duced Aldh1a2 expression in BM-DCs, but the treatment
with other cytokines including IL-3, IL-5, IL-6, IL-10, IL-12,
IFN-a, IFN-b, IFN-c, TNF-a, TGF-b1, TGF-b2, TSLP or
CX3CL1 failed to induce or enhance the expression (Fig. 2C).
The antigenic stimulation in the intestine tends to induce
Th2-type responses or tolerance with Treg (25). Thus, IL-4,
IL-13, IL-10 or TGF-b appears to be more commonly in-
duced in the intestine than in other tissues. The results indi-
cate that IL-4 and IL-13 but neither IL-10 nor TGF-b may
contribute to induce the ALDH1A2 expression in intestinal
DCs especially upon immune responses. The peroxisome
proliferator-activated receptor c agonist rosiglitazone and
the liver X receptor agonist TO901317 were suggested to
induce Aldh1a1 or Aldh1a2 expression in some cells or tis-
sues (26, 27). They failed to induce the expression in BM-
DCs (Fig. 2C), but weakly induced the Aldh1a2 expression
when they were added at an early stage of the BM-DC
development (data not shown). IEC-derived eicosanoids
modulate some DC functions (28). However, neither prosta-
glandin E2 nor leukotriene B4 affected the Aldh1a2 expres-
sion (Fig. 2C).
GM-CSF and IL-4 synergistically induce ALDH1A2 expression
in DCs
We also found that the combination of GM-CSF and IL-4
synergistically induced Aldh1a2 expression and ALDHact in
BM-DCs and more efﬁciently in SPL-DCs and PLN-DCs (Fig.
2D and E and data not shown). We conﬁrmed the produc-
tion of ALDH1A2 protein in BM-DCs and SPL-DCs treated
with the combination of GM-CSF and IL-4 (Fig. 2F). On the
364 GM-CSF triggers dendritic cells to express ALDH1A2Fig. 1. MLN-DCs and PP-DCs express Aldh1a2 and possess ALDHact. (A) Expression of ALDH1A2 in CD11c
 or CD11c
+ cells from MLN or SPL of
B10.D2 mice was analyzed by immunoblotting. Data are representative of two independent experiments. (B) Expression of Aldh1a1, Aldh1a2,
Aldh1a3, Aldh8a1, Cyp1b1, Cyp2j6 and Rplp0 as a loading control in CD11c
 or CD11c
+ c e l l sf r o mM L N ,P Po rS P Lw a sa n a l y z e db yR T - P C R .D a t a
are representative of two independent experiments. (C) Expression of Aldh1a2 in CD103
+ or CD103
 DCs from MLN or PP was analyzed by
quantitative real-time PCR. Data are presented as mean 6 SEM and are representative of three independent experiments. Statistical signiﬁcance was
determined by the one-way analysis of variance; ***P < 0.001. (D) Cells from MLN or PP were incubated with ALDEFLUOR, co-stained for CD11c and
CD3e, CD19, CD49b, F4/80 or Gr-1 and analyzed by ﬂow cytometry. Pre-gated CD11c
 cells are shown in the dot plots except those for CD11c
staining. Data are representative of two independent experiments. (E) MLN-DCs, PP-DCs or SPL-DCs were incubated with ALDEFLUOR in the
presence (bottom) or absence (top) of the ALDH inhibitor DEAB and stained for CD11c expression. Numbers adjacent to gates indicate percentage of
ALDHact
high cells (upper number) or ALDHact
intermediate cells (lower number). Data are representative of three independent experiments. (F)
ALDEFLUOR-treated MLN-DCs were co-stained for CD11c and B220, CD4, CD8a, CD11b, CD45RB, CD86, F4/80, MHC class II or CD103 expression.
ALDHact
high and ALDHact
/intermediate cells are shown as red and blue dots, respectively. Data are representative of two independent experiments.
GM-CSF triggers dendritic cells to express ALDH1A2 365Fig. 2. GM-CSF and IL-4 synergistically induce ALDH1A2 expression in DCs. (A) Expression of Aldh1a2 in GM-CSF-induced or Flt3L-induced BM-
DCs was analyzed by quantitative real-time PCR. Data are presented as mean 6 SEM and are representative of three independent experiments.
Statistical signiﬁcance was determined by the Student’s t test; ***P < 0.001. (B) Expression of Aldh1a2 in Flt3L-induced BM-DCs (left) and SPL-DCs
(right) cultured with graded concentrations of GM-CSF was analyzed by quantitative real-time PCR. Data are presented as mean 6 SEM and are
representative of three independent experiments. Statistical signiﬁcance was determined by the one-way analysis of variance (ANOVA). ***P < 0.001
versus untreated. (C) Flt3L-induced BM-DCs were cultured with IL-3 (10 ng ml
1), IL-4 (10 ng ml
1), IL-5 (10 ng ml
1), IL-6 (10 ng ml
1), IL-10 (10 ng
ml
1), IL-12 (10 ng ml
1), IL-13 (10 ng ml
1), IFN-a (10
4 Um l
1), IFN-b (10
4 Um l
1), IFN-c (10 ng ml
1), TNF-a (10 ng ml
1), TGF-b1 (10 ng ml
1),
TGF-b2 (10 ng ml
1), TSLP (10 ng ml
1), CX3CL1 (10 ng ml
1), prostaglandin E2 (PGE2;1 0
6 M) or leukotrien B4 (LTB4;1 0
7 M). The expression of
Aldh1a2 was assessed by semi-quantitative real-time PCR. The mRNA expression of treated cells is expressed as the ‘fold induction’ relative to that
of untreated cells. Data are presented as mean 6 SEM and are representative of two independent experiments. (D–F) Flt3L-induced BM-DCs (left) or
SPL-DCs (right) were cultured with medium alone (none), GM-CSF (10 ng ml
1), IL-4 (10 ng ml
1)o rG M - C S Fa n dI L - 4( 1 0n gm l
1 each). (D)
Expression of Aldh1a2 was analyzed by quantitative real-time PCR. Data are presented as mean 6 SEM and are representative of more than three
independent experiments. Statistical signiﬁcance was determined by the one-way ANOVA. ***P < 0.001 versus all samples. (E) The cultured DCs
were incubated with ALDEFLUOR in the presence (solid lines) or absence (shaded histograms) of DEAB and were analyzed by ﬂow cytometry.
Numbers in histogram plots indicate percentage of ALDHact
+ cells. Data are representative of more than three independent experiments. (F)
Expression of ALDH1A2 in DCs cultured with GM-CSF and IL-4 was analyzed by immunoblotting. Numbers below immunoblot indicate the signal
intensity of treated DCs. Data are representative of two independent experiments.
366 GM-CSF triggers dendritic cells to express ALDH1A2other hand, the combination or each cytokine failed to in-
duce the expression of Aldh1a1, Aldh1a3 or Aldh8a1 in BM-
DCs or SPL-DCs (data not shown).
TLR ligands enhance ALDH1A2 expression in BM-DCs
In germ-free mice, intestinal T cells do not increase after
birth (29), indicating that commensal bacteria affect the de-
velopment or immigration of gut mucosal T cells. DCs in the
intestine appear to have chances to capture components of
commensal bacteria even under normal steady-state condi-
tions (30). TLRs and nucleotide-binding oligomerization do-
main proteins (Nod1 and Nod2) are key pattern recognition
receptors that bind to conserved molecular patterns unique
to prokaryotes and mediate innate host defense in the intes-
tinal mucosa (31, 32). All the TLR ligands we tested, but not
the Nod ligand sPGN, signiﬁcantly enhanced GM-CSF/IL-4-
induced Aldh1a2 expression (Fig. 3A) and the number of
ALDHact
+ (Fig. 3B and data not shown) in BM-DCs. TLR
ligands up-regulated the CD86 expression (Fig. 3B). Ac-
cordingly, ALDHact
+ DCs in MLN were CD86
high (Fig. 1F).
BM-DCs treated with GM-CSF, IL-4 and a TLR ligand for
48 h exhibited high ALDH activities comparable to those
in MLN-DCs in normal mice (Figs 1E and 3B). They were
B220
, CD45RB
low, CD80
high and MHC class II
high, indicat-
ing that they were mature non-plasmacytoid DCs. The phe-
notype of the ALDHact
+ BM-DCs corresponds to that of
the ALDHact
+ MLN-DCs except for the CD8a and CD11b
expressions (Figs 1F and 3C). These cells were F4/80
, indi-
cating that they were DCs but not macrophages. The CD103
expression was low in BM-DCs, but was up-regulated upon
treatment with GM-CSF, IL-4 and LPS (Fig. 3C).
In SPL-DCs, TLR ligands enhanced the IL-4-induced
Aldh1a2 expression, but failed to enhance the GM-CSF-
induced expression (Fig. 3D). GM-CSF with IL-4 induced
high levels of ALDHact in SPL-DCs, and no further enhance-
ment was observed with additional TLR stimulation (Fig. 3E).
Similar results were obtained with PLN-DCs (data not
shown).
DCs treated with GM-CSF and IL-4 and/or a TLR ligand
induce gut-homing receptor expression on T cells and Treg
differentiation
We examined if the generated ALDH1A2
+ DCs could trigger
T cells to express the gut-homing receptors, the integrin
a4b7 and the chemokine receptor CCR9 (33, 34). BM-DCs
treated with GM-CSF and/or IL-4 together with LPS induced
CCR9 expression, enhanced a4b7 expression and sup-
pressed the expression of the skin-homing receptors,
E-selectin ligands, on T cells upon antigenic stimulation
(Fig. 4). SPL-DCs treated with both GM-CSF and IL-4 did so
even without the LPS treatment (Supplementary Figure 3 is
available at International Immunology Online). The induction
of CCR9 expression was almost completely inhibited by
DEAB, indicating that de novo synthesis of RA was essential
for the expression. The a4b7 expression was partly sup-
pressed by DEAB. Unlike CCR9 expression, a4b7 expres-
sion can be induced to some extent on T cells in vitro even
without RA (1, 18). DEAB restored the suppressed expres-
sion of E-selectin ligands (Fig. 4 and Supplementary Figure 3
is available at International Immunology Online). BM-DCs
treated with other cytokines including IL-12 and TGF-b failed
to induce gut-homing receptors on T cells (data not shown).
These results suggest that Aldh1a2
+ and ALDHact
+ DCs in-
duced with GM-CSF and IL-4 and/or a TLR ligand can in-
duce or enhance gut-homing receptors on T cells.
We also examined if ALDH1A2
+ DCs generated in vitro
could promote the TGF-b1-dependent differentiation of naive
T cells to Foxp3
+ T cells and the TGF-b1/IL-6/IL-23-
dependent differentiation to Th17 cells. SPL-DCs treated with
GM-CSF and/or IL-4 could more efﬁciently induce Foxp3
+
T cells (Fig. 5A and B) and less efﬁciently induce Th17 cells
(Fig. 5C and D) than control SPL-DCs. In the presence of
DEAB, however, these effects were largely canceled, indi-
cating that de novo synthesis of RA by DCs affected the
T-cell differentiation.
GM-CSF is a major physiological inducer of the ALDH1A2
expression in intestinal DCs
To examine if GM-CSF plays a physiological role in inducing
the ALDH1A2 expression in intestinal DCs, we analyzed
GM-CSF receptor-deﬁcient mice, which were deﬁcient of the
common b subunit (Beta-c) of GM-CSF/IL-3/IL-5 receptor
(35). These mice show normal DC development deﬁned by
myeloid- and lymphoid-related DC markers, except for a de-
crease in the DC numbers in their lymph nodes (LN) (36).
We found, however, that the mean ALDHact in MLN-DCs
from Beta-c
/ mice was markedly lower than that from wt
mice (Fig. 6A). The ALDHact in PP-DCs was also affected
by Beta-c deﬁciency. Accordingly, MLN-DCs from Beta-c
/
mice less efﬁciently induced the expression of CCR9 and
a4b7 than those from wt mice (Fig. 6B). Furthermore, the
number of CD4
+ cells in the small intestinal LP in Beta-c
/
mice was markedly lower than that in wt mice (Fig. 6C). The
number of CD8
+ cells in LP and the intra-epithelial spaces
was also reduced in Beta-c
/ mice (Fig. 6D). The distribu-
tions of CD4
+ cells and CD8
+ cells in PP of Beta-c
/ mice
were similar to those of wt mice, although the sizes of PP of
Beta-c
/ mice were smaller than those of wt mice (Fig. 6C
and D). No difference was observed in the distribution of
CD4
+ cells in the liver of these mice (Fig. 6E, left). In the
lung of Beta-c
/ mice, however, the number of CD4
+ cells
was signiﬁcantly higher than that of wt mice (Fig. 6E, right),
probably due to the alveolar proteinosis that is commonly
developed in these mice (35, 37–39). We have previously
shown that vitamin A deﬁciency affects IgA
+ cell frequencies
in PP and MLN (2). Similarly, IgA
+ cell frequencies in PP and
MLN were signiﬁcantly reduced in Beta-c
/ mice (Fig. 6F).
As only GM-CSF but not the other Beta-c-sharing cytokines,
IL-3 or IL-5, could induce ALDH1A2 expression in DCs (Fig. 2),
these results suggest that GM-CSF is a major physiological in-
ducer of the ALDH1A2 expression in intestinal DCs in SPF
mice under steady-state condition.
Colonic epithelial cells produce GM-CSF upon exposure
to certain stimuli including pathogenic bacteria (40). How-
ever, the small intestinal IECs in normal SPF mice did
not signiﬁcantly express Csf2 mRNA (encoding GM-CSF)
(Fig. 7A). On the other hand, CD11c
F4/80
+ cells in MLN
but not those in SPL or PLN expressed Csf2 (Fig. 7A).
GM-CSF triggers dendritic cells to express ALDH1A2 367Fig. 3. TLR-mediated maturation signals enhance Aldh1a2 expression and ALDHact in BM-DCs. Flt3L-induced BM-DCs (A–C) or SPL-DCs (D
and E) were cultured with medium alone (none), sPGN (10 lgm l
1), poly(I:C) (1 lgm l
1), LPS (1 lgm l
1), R837 (1 lgm l
1) or CpG ODN 1826
(CpG; 1 lM) in the presence or absence of GM-CSF and/or IL-4 (10 ng ml
1 each). (A and D) Expression of Aldh1a2 was assessed by semi-
quantitative real-time PCR. The mRNA expression of treated cells is expressed as the ‘fold induction’ relative to that of untreated cells (cultured
with medium alone without GM-CSF or IL-4). (B and E) DCs were cultured with medium alone or LPS in the presence or absence of GM-CSF and
368 GM-CSF triggers dendritic cells to express ALDH1A2Indeed, GM-CSF
+ cells were found outside of the follicles in
MLN and PP and in the intestinal LP (Fig. 7B). Many of the
GM-CSF
+ cells were CD11c
F4/80
+ (Fig. 7B and 7C, left),
whereas, such cells were not found in the brachial LN (Fig.
7C, right). The results suggest that GM-CSF is constitutively
produced by macrophages or granulocytes but not DCs in
the intestinal tissues.
We also analyzed mice deﬁcient of the IL-4 receptor
a chain (41). IL-4Ra is a common component shared by
IL-4 and IL-13 receptors. ALDH activities in the intestinal
DCs from IL-4Ra-deﬁcient mice were comparable to or
rather higher than those from wt mice (Supplementary Figure
4 is available at International Immunology Online). The
results indicate that the IL-4 receptor-mediated signals are
dispensable for the ALDH1A2 expression in intestinal DCs.
Vitamin A is essential for the Csf2 expression in non-DCs in
MLN
Swine monocyte-derived DCs pretreated with 1 lMR A
instructed lymphocytes to enhance the expression of a4, b7
and Ccr9 (19). Accordingly, Aldh1a2 expression and ALD-
Hact in MLN-DCs from vitamin A-deﬁcient mice were dramati-
cally lower than those from control mice (Fig. 8A and B),
suggesting that vitamin A is essential for ALDH1A2 expres-
sion in MLN-DCs. All-trans-RA even at 1 lM weakly or hardly
induced Aldh1a2 expression in BM-DCs or SPL-DCs, respec-
tively (Fig. 8C), but moderately enhanced GM-CSF and/or
IL-4-induced Aldh1a2 expression in BM-DCs (data not
shown). 9-cis-RA exerted similar effects (data not shown). Ac-
cordingly, in the presence of the retinoic acid receptor (RAR)
pan-antagonist LE540 (42), the GM-CSF-induced expression
IL-4, incubated with ALDEFLUOR and co-stained for CD11c and CD86 expression. (C) BM-DCs were cultured with LPS, GM-CSF and IL-4,
incubated with ALDEFLUOR and co-stained for CD11c and B220, CD4, CD8a, CD11b, CD45RB, CD80, CD103, F4/80 or MHC class II
expression. ALDHact
+ cells are shown as red dots. All data are representative of two independent experiments.
Fig. 4. DCs treated with GM-CSF or IL-4 and/or LPS induce the expression of gut-homing receptors on CD4
+ Tcells. Flt3L-induced BM-DCs were
treated with medium alone (none), GM-CSF (10 ng ml
1), IL-4 (10 ng ml
1) or GM-CSF and IL-4 (10 ng ml
1 each). To promote full maturation of
BM-DCs, LPS (1 lgm l
1) was added to their cultures. The treated DCs were pulsed with OVA peptide P323-339 (1 lM) and co-cultured with
naive DO11.10 CD4
+ Tcells at a ratio of 1:5 in the presence or absence of DEAB (100 lM). On day 5 of culture, cells were stained for CCR9 (top),
a4b7 (middle) and E-selectin ligands (bottom) and analyzed by ﬂow cytometry. (A) The expression levels are presented as DMFI. Data are
presented as mean 6 SEM and are representative of more than three independent experiments. Statistical signiﬁcance was determined by the
one-way analysis of variance; ***P < 0.001. (B) Histogram plots of each staining of Tcells co-cultured with untreated or GM-CSF + IL-4-treated
DCs are shown. Shaded histograms and solid lines indicate speciﬁc staining and isotype control, respectively. Numbers in histogram plots
indicate DMFI.
GM-CSF triggers dendritic cells to express ALDH1A2 369of Aldh1a2 was reduced by 70 and 30% in BM-DCs and SPL-
DCs, respectively (Fig. 8D). There was a possibility that SPL-
DCs prestored RA in vivo despite their inability to produce
RA by themselves, and thus required less RA than BM-DCs
in vitro. However, the effects of RA or LE540 on SPL-DCs from
vitamin A-deﬁcient mice were similar to those on SPL-DCs
from control mice (data not shown), suggesting that the pos-
sibility is unlikely. These results indicate that RA-mediated sig-
nals contribute to the GM-CSF-induced ALDH1A2 expression
in BM-DCs but to a much lesser extent in SPL-DCs.
We also found that the Csf2 expression in CD11c
F4/80
+
cells in MLN was markedly reduced in vitamin A-deﬁcient
mice (Fig. 8E), suggesting that vitamin A is essential for the
GM-CSF production in MLN.
Discussion
RA production by intestinal DCs appears to be critical for
gut immunity and tolerance. However, it has remained un-
solved which DC subsets are responsible for the RA
production and how they acquire their RA-producing
capacity. Here, we identiﬁed CD11c
highCD4
/low
CD8a
intermediateCD11b
/lowF4/80
low/intermediateCD45RB
lowCD86
high
MHC class II
highB220
CD103
+ c e l l sa st h eD C se x p r e s s i n gt h e
major RA-synthesizing enzyme, ALDH1A2, in MLN and PP of
normal SPF mice. Especially, CD8a
intermediateCD103
high MLN-
DCs highly expressed Aldh1a2 (Supplementary Figure 1
is available at International Immunology Online). MLN-
DCs are derived from three sources: the blood, LP and
PP (43). A subset of the LP-derived DCs was
CD11c
highCD8a
intermediateCD11b
lowaL
lowb7
high (44). Since the
Aldh1a2
+ and ALDHact
+ DCs are a minor DC population in PP
in normal SPF mice (Fig. 1), ALDH1A2
+ D C si nM L Nm a yb e
derived largely from LP and slightly from PP. In LP, at least two
cell populations, CD103
+CD11b
/low DCs and CD11b
+F4/80
+
macrophages, appear to be potential RA producers or their
precursors (6, 9), and these DCs but not macrophages may
Fig. 5. DCs treated with GM-CSF and/or IL-4 enhance the differentiation of Foxp3
+ Tcells, but suppress the differentiation of Th17 cells. (A and B)
SPL-DCs were treated with medium alone (none), GM-CSF (10 ng ml
1), IL-4 (10 ng ml
1) or GM-CSF and IL-4 (10 ng ml
1 each) and co-cultured
with naive DO11.10 CD4
+ Tcells at a ratio of 1:10 in the presence of OVA peptide P323-339 (1 lM) and IL-2 (100 U ml
1) with or without TGF-b1
(5 ng ml
1). DEAB (100 lM) was added to some culture wells. On day 5 of culture, cells were stained for intracellular Foxp3 and analyzed by ﬂow
cytometry. (A) The graph shows the mean 6 SEM of percentage of Foxp3
+ T cells generated in each culture condition. (B) Histogram plots of
T cells co-cultured with untreated or GM-CSF + IL-4-treated DCs are shown. Shaded histograms and solid lines indicate speciﬁc staining and
isotype control, respectively. The number shown in each panel indicates the percentage of Foxp3
+ cells. (C and D) The treated DCs were co-
cultured with naive DO11.10 CD4
+ Tcells as described in (A and B), but IL-6 and IL-23 (20 ng ml
1 each) were also included in the culture. On
day 5 of culture, cells were re-stimulated for 5 h with phorbol 12-myristate 13-acetate and ionomycin and stained for intracellular IL-17 and IFN-c.
(C) The graph shows the mean 6 SEM of percentage of IL-17
+IFN-c
 cells generated in each culture condition. (D) Dot plots of Tcells co-cultured
with untreated or GM-CSF + IL-4-treated DCs are shown. The number shown in each panel indicates the percentage of IL-17
+IFN-c
 cells. All
data are representative of two independent experiments. Statistical signiﬁcance was determined by the one-way analysis of variance;
***P < 0.001.
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+ DCs generated in
PP might quickly migrate into MLN, or ALDH1A2 expression
might be also induced in DCs after migrating into MLN. Re-
cently, it has been shown that a subset of LP-DCs with a macro-
phage-like character (CD11c
highCD11b
highCD86
highCD103
+F4/
80
moderate) also expresses Aldh1a2 (15).
Fig. 6. GM-CSF receptor-mediated signals are critical for MLN-DCs to acquire ALDHact and the capacity to imprint gut-homing speciﬁcity on
T cells. (A) Cells from MLN, PP or SPL of wt or Beta-c
/ mice were incubated with ALDEFLUOR and stained for CD11c expression. Values
indicate DMFI of ALDEFLUOR in CD11c
+ cells. Data are presented as mean 6 SEM (four mice in each genotype). Statistical signiﬁcance was
determined by the Student’s t test. ***P < 0.001 versus wt mice. (B) MLN-DCs were isolated from Beta-c
/ or wt mice and co-cultured with
naive CD4
+ Tcells from wt mice at a ratio of 1:5 in the presence of soluble anti-CD3e mAb (1 lgm l
1). DEAB (100 lM) was added to some wells.
On day 5 of culture, the expression levels of CCR9 (left) and a4b7 (right) on T cells were analyzed by ﬂow cytometry. Data are presented as
mean 6 SEM and are representative of two independent experiments. Statistical signiﬁcance was determined by the one-way analysis of
variance; ***P < 0.001. (C–E) Immunohistochemical analysis was performed on CD4
+ cells or CD8
+ cells in PP, villi of small intestine, liver or lung
from wt or Beta-c
/ mice. Frozen sections were stained for CD4 (C and E, red) or CD8 (D, red). Cell nuclei were visualized with TO-PRO-3 (blue).
Data are representative of two independent experiments. Scale bars, 200 lm (PP); 50 lm (villi, liver and lung). (F) Cells from PP, MLN or SPL of wt
or Beta-c
/ mice were stained for B220 and IgA. The graph shows the mean 6 SEM (four mice in each genotype) of percentage of IgA
+ cells in
B220
+ cells. Statistical signiﬁcance was determined by the Student’s t test. **P < 0.01 versus wt mice. Dot plots of pre-gated B220
+ cells from PP
are shown. Numbers adjacent to gates indicate percentage of IgA
+ cells.
GM-CSF triggers dendritic cells to express ALDH1A2 371GM-CSF appears to play a physiological role to induce the
ALDH1A2 expression in intestinal DCs. GM-CSF
+ cells were
detected in the intestinal tissues of normal SPF mice, and
many of them were CD11c
F4/80
+. Macrophages (9) or
eosinophil-like cells (44) may contribute to the GM-CSF pro-
duction in the intestinal tissues. IECs did not produce GM-
CSF without exposure to pathogenic bacteria, but may
produce it with these stimuli. GM-CSF is also constitutively
expressed in BM. However, fresh CD11c
+ BM cells
expressed very low levels of Aldh1a2 (data not shown).
CD11c
+ BM cells may be too immature to express high lev-
els of ALDH1A2 upon exposure to GM-CSF. Alternatively,
collaborative factors including RA, IL-4 and TLR ligands
may not be enough in BM. GM-CSF is also required for
maintaining ALDH1A2 expression since GM-CSF-induced
Aldh1a2 expression in BM-DCs decreased when the culture
was extended in the absence of GM-CSF (Supplementary
Figure 2 is available at International Immunology Online). Pe-
ripheral blood monocyte-derived DCs cultured in GM-CSF
and IL-4 are likely to express ALDH1A2 as well, but may
lose it with an extended culture without GM-CSF. DCs gener-
ated with GM-CSF and IL-4 are widely used for research or
therapeutic purposes. Our results suggest that these cells
express ALDH1A2 immediately after the generation.
Beta-c deﬁciency caused marked reductions in the ALD-
Hact in MLN-DCs and the T cell number in LP. Beta-c is a
common component of receptors of GM-CSF, IL-3 and IL-5,
but only GM-CSF induced ALDH1A2 expression in wt DCs.
In IL-5 receptor-deﬁcient mice, there were normal numbers
of IL-4-, IL-5- or IL-6-producing cells in LP (45), implying that
IL-5 signals may not be essential for the T-cell distribution in
LP. IL-3 signals can be transduced through an alternative
IL-3 receptor b in the absence of Beta-c in mice (39). There-
fore, the above-mentioned reductions in Beta-c-deﬁcient
mice are likely to be due to the lack of GM-CSF-dependent
signals. However, the reductions were not as severe as
those observed in vitamin A-deﬁcient mice (1). The GM-
CSF-dependent signals might be partly compensated by
IL-4, IL-13, TLR ligands or other unknown stimuli. Accord-
ingly, it has been recently shown that IL-4 enhanced the
Aldh1a2 expression in MLN-DCs and that T cells stimulated
with MLN-DCs from IL-4Ra-deﬁcient mice exhibited lower
CCR9 expression than T cells stimulated with wt MLN-DCs
(46). Although IL-4/IL-13-dependent signals were dispens-
able for the ALDH1A2 expression in DCs, they might be pro-
duced and contribute to the expression, especially during
immune responses in the presence of RA and TLR-mediated
signals in the gut.
Myeloid differentiation primary response gene 88 (MyD88)
is a central adaptor shared by almost all TLRs (47, 48), but
the numbers of intra-epithelial lymphocytes and LP lympho-
cytes are comparable between wt and MyD88
/ intestines
(49). It remains to be solved if TLR-mediated signals are es-
sential for the ALDH1A2 expression since TIR domain con-
taining adaptor-inducing IFN-b-dependent pathways could
be contributing to the signals in these mice. Nonetheless,
any combinations of two from GM-CSF, IL-4 and a TLR
ligand synergistically induced both Aldh1a2 expression
and ALDHact in BM-DCs. Three of them further strongly
induced the expression and activity. Their ALDHact was
comparable to that found in ALDHact
high MLN-DCs. Ac-
cordingly, it was recently reported that the Aldh1a2 expres-
sion in CD11c
highCD11b
high LP-DCs was enhanced upon
Fig. 7. GM-CSF
+CD11c
F4/80
+ cells constitutively exist in MLN, PP
and the intestinal LP. (A) IECs were isolated from the jejunum and
ileum of B10.D2 mice. CD11c
F4/80
+ cells were isolated from SPL,
PLN and MLN of the same mice. The mRNA expression of Csf2 was
assessed by quantitative real-time PCR. Data are presented as mean
6 SEM and are representative of two independent experiments.
(B) Frozen sections of MLN, PP or the intestinal LP were co-stained for
GM-CSF (red) and CD11c (left, green) or F4/80 (right, green). (C)
Frozen sections of MLN or PLN (brachial LN) were stained for
GM-CSF (red) and F4/80 (green). Cell nuclei were visualized with
TO-PRO-3 (blue). Data are representative of two independent
experiments. Scale bars, 50 lm.
372 GM-CSF triggers dendritic cells to express ALDH1A2TLR5-mediated stimulation (15). Since ALDH1A2
+ MLN-DCs
were mature CD86
high DCs, maturation of DCs is likely to be
required for inducing the high levels of ALDH1A2 expres-
sion. Indeed, TLR-mediated signals also induced maturation
of BM-DCs in the presence of GM-CSF and IL-4 (Fig. 3A
and B). On the other hand, most SPL-DCs became CD86
+
cells after 24 h of culture even without TLR-mediated stimu-
lation (Fig. 3E). Accordingly, neither TLR-mediated signals
nor IL-4 were required for inducing high levels of ALDHact
in SPL-DCs in the presence of GM-CSF. Indeed, depending
on the ALDHact, SPL-DCs treated with GM-CSF and/or IL-4
without LPS signiﬁcantly induced CCR9 expression on
T cells (Supplementary Figure 2 is available at International
Immunology Online). However, the increase in a4b7 expres-
sion on T cells was moderate even when SPL-DCs were pre-
treated with both GM-CSF and IL-4. The pretreated SPL-DCs
might also provide a factor or signal that interfered with the
RA-induced a4b7 expression. Nonetheless, DEAB partly but
signiﬁcantly suppressed the a4b7 expression. The pretreated
SPL-DCs also enhanced the differentiation of naive CD4
+ T
cells to Foxp3
+ T cells but suppressed that to Th17, and
these effects were canceled by DEAB (Fig. 5). Accordingly,
in vivo administration of GM-CSF has been shown to induce
anti-inﬂammatory DCs and Tregs and suppress autoimmune
disorders, such as experimental autoimmune thyroiditis, type
I diabetes and myasthenia gravis (50–53). The GM-CSF ad-
ministration also decreased the severity of Crohn’s diseases
(54). These beneﬁcial effects of GM-CSF might involve the
ALDH1A-dependent mechanism. Interestingly, GM-CSF is
also known as an inﬂammatory cytokine. It has recently been
reported that GM-CSF was critical for IL-6 and IL-23
responses by DCs and thus critical for generation of Th17
cells in vivo (55). Frequencies of IL-17-producing cells in the
small intestinal LP of Beta-c
/ mice were indeed lower than
those of wt mice (Supplementary Figure 5 is available at In-
ternational Immunology Online), as found in immunized GM-
CSF
/ mice. Various factors during antigen priming might
affect the preferential development of Th17 or Treg. TGF-b is
another example with dual functions for inducing the devel-
opment of Th17 and Treg. RA itself might also have the dual
functions depending on its concentration. A low concentra-
tion of RA was suggested to be required for Th17 develop-
ment, although high concentrations of RA suppressed it
(15). After the Th17 development, Th17 cells may produce
GM-CSF, which may then contribute to a feedback suppres-
sion of Th17 development by enhancing ALDH1A2 expres-
sion and RA production in DCs.
DEAB only partly inhibited the a4b7 expression induced
by wt MLN-DCs as well, and the residual expression was
Fig. 8. Vitamin A is essential for GM-CSF-induced Aldh1a2 expres-
sion in DCs and Csf2 expression in CD11c
F4/80
+ cells in MLN.
(A) Expression of Aldh1a2 in MLN-DCs from control or vitamin
A-deﬁcient (DVit.A) mice was analyzed by quantitative real-time PCR.
Data are presented as mean 6 SEM and are representative of two
independent experiments. Statistical signiﬁcance was determined by
the Student’s t test; ***P < 0.001. (B) Cells from MLN of control or
vitamin A-deﬁcient mice were incubated with ALDEFLUOR and
stained for CD11c expression. Values indicate DMFI of ALDEFLUOR
in CD11c
+ cells. Data are presented as mean 6 SEM (four mice in
each group). Statistical signiﬁcance was determined by the Student’s
t test; ***P < 0.001. (C) Expression of Aldh1a2 in Flt3L-induced BM-
DCs (left) or SPL-DCs (right) cultured with medium alone (none), all-
trans-RA (1 lM) or GM-CSF (10 ng ml
1) was analyzed by
quantitative real-time PCR. Data are presented as mean 6 SEM
and are representative of two independent experiments. Statistical
signiﬁcance was determined by the one-way analysis of variance
(ANOVA); ***P < 0.001. (D) Expression of Aldh1a2 expression in
Flt3L-induced BM-DCs (left) or SPL-DCs (right) cultured with GM-CSF
(10 ng ml
1) in the presence or absence of LE540 (1 lM) was
analyzed by quantitative real-time PCR. Data are presented as mean
6 SEM and are representative of two independent experiments.
Statistical signiﬁcance was determined by the one-way ANOVA;
***P < 0.001. (E) Expression of Csf2 in CD11c
+, CD11c
F4/80
+ or
CD11c
F4/80
 cells from MLN of control or vitamin A-deﬁcient mice
was analyzed by quantitative real-time PCR. Data are presented as
mean 6 SEM and are representative of two independent experiments.
Statistical signiﬁcance was determined by the one-way ANOVA.
***P < 0.001 versus control mice.
GM-CSF triggers dendritic cells to express ALDH1A2 373equivalent to the a4b7 expression induced by Beta-c
/
MLN-DCs in the presence or absence of DEAB (Fig. 6B,
right), suggesting that there are RA-dependent and RA-
independent pathways to induce a4b7. On the other hand,
the CCR9 expression induced by wt MLN-DCs or GM-CSF/
IL-4-treated BM-DCs or SPL-DCs was almost completely
inhibited by DEAB [Fig. 4A, top and Fig. 6B, left and Supple-
mentary Figure 3, left (available at International Immunology
Online], indicating that de novo synthesis of RA in these
DCs was essential for the CCR9 expression and that
there was little prestored RA pool, if any, in these DCs. Alter-
natively, the expression of CCR9 might require higher
concentrations of RA than that of a4b7 and a low concentra-
tion of preformed RA in the DCs might only affect a4b7
expression.
Since IECs strongly express ALDH1A1 (RALDH1), they
may produce RA from dietary vitamin A or blood-derived ret-
inol (1, 56) and may provide it to adjacent DCs. Ham-
merschmidt et al. (57) have recently suggested that a small
number of stromal cells in MLN expressed Aldh1a1, Aldh1a2
and Aldh1a3 and might contribute to imprinting gut-homing
speciﬁcity on T cells in the presence of DCs . Although RA
by itself only poorly induced Aldh1a2 expression in DCs
and moderately enhanced the GM-CSF and/or IL-4-induced
expression of Aldh1a2 in BM-DCs in our culture systems,
the RAR antagonist LE540 signiﬁcantly suppressed the GM-
CSF-induced expression of Aldh1a2 in BM-DCs (Fig. 7C
and D), suggesting that the GM-CSF-induced expression of
ALDH1A2 may largely depend on an autocrine loop of RA
generated from serum retinol in the culture. The stromal cells
in MLN and IECs might provide the initial RA to DCs to ac-
quire the GM-CSF responsiveness for the expression of
ALDH1A2 in MLN and/or PP in vivo. Within the 3-kb region
upstream of the murine Aldh1a2 gene, there are multiple
signal transducers and activators of transcription (STAT)-
binding motifs and putative RAR-binding motifs, which may
contribute to the synergistic effect by GM-CSF and RA. GM-
CSF and RA synergistically induce several other genes in
myeloid cells, involving Janus kinase (JAK) 2 activation (58).
Present results suggest that vitamin A is essential for both
ALDH1A2 expression in MLN-DCs and GM-CSF expression
in F4/80
+ non-DCs in MLN. It has been reported that
Fig. 9. Proposed model for the mechanism of GM-CSF-mediated induction of RA-producing DCs in the intestinal tissues. GM-CSF plays a critical
role to induce the ALDH1A2 expression in DCs. In the intestinal tissues, CD11c
F4/80
+ cells (i.e. macrophages or granulocytes) produce GM-
CSF, which induces the ALDH1A2 expression in DCs. DC maturation signals induced by intestinal stimuli including TLR ligands from intestinal
bacterial ﬂora enhance the ALDH1A2 expression. The ALDH1A2
+ DCs produce RA and imprint gut-homing speciﬁcity on Tcells upon antigenic
stimulation. These DCs also promote the differentiation of naive Tcells to Foxp3
+ Treg cells in the presence of TGF-b. RA is required not only for
the GM-CSF-induced expression of ALDH1A2 in DCs but also for the GM-CSF production by CD11c
F4/80
+ cells or their proper migration. Thus,
ALDH1A2
+ DCs as well as ALDH1A1
+ IECs may provide RA to DCs and CD11c
F4/80
+ cells and enhance the positive feedback loop for RA
production in the intestine.
374 GM-CSF triggers dendritic cells to express ALDH1A2RA stimulates BM stromal cells to produce GM-CSF (59).
However, it remains to be solved if RA is involved in the in-
duction of CD11c
GM-CSF
+ cells or their migration to MLN.
Our previous experiments suggested that some PP-DCs
expressed ALDH1A1 in B10.D2 mice that were maintained
in a clean conventional animal facility (1). In the same strain
of mice kept in an SPF animal facility, however, Aldh1a1 ex-
pression was not detected in PP-DCs. We detected low
levels of Aldh1a1 expression in SPL-DCs from BALB/c mice
but not in those from B10.D2 mice (data not shown). Animal
strains and/or the environment might affect ALDH1A1 ex-
pression in DCs. Since GM-CSF, IL-4, TLR ligands or RA did
not induce ALDH1A1 expression in DCs, ALDH1A1 and
ALDH1A2 differ in their induction mechanisms.
The present results collectively indicate that multiple fac-
tors in the intestinal microenvironment affect the expression
of ALDH1A2 in DCs. Although it is still possible that yet-to-
be-discovered factors might also contribute to the expres-
sion, GM-CSF appears to play a major role, and TLR ligands
and RA may play supporting roles (Fig. 9). In addition, IL-4
and/or IL-13 that can be produced during immune
responses in the gut may also contribute to the ALDH1A2
expression. The results may also suggest a possibility that
local immune responses involving the production of GM-
CSF and/or IL-4 or exposure to TLR ligands might affect
ALDH1A2 expression in local DCs even in non-intestinal tis-
sues, although the lack of RA or unknown inhibitory factors
might limit the expression. RA regulates not only the homing
speciﬁcity of lymphocytes but also the differentiation of Treg
and Th17 and is thus likely to control gut immunity and oral
tolerance. Therefore, the induction of ALDH1A2 expression
in intestinal DCs is critical for the regulation of immune and
inﬂammatory responses, and it might be a new target for
drug discovery.
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Supplementary Tables 1 and 2 and Figures 1–5 are available
at International Immunology Online.
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Abbreviations
ALDH aldehyde dehydrogenase
ALDHact aldehyde dehydrogenase activity
APC allophycocyanin
BM-DC bone marrow-derived dendritic cell
DC dendritic cell
DEAB diethylaminobenzaldehyde
Flt3L fms-like tyrosine kinase 3 ligand
GM-CSF granulocyte-macrophage colony-stimulating factor
IEC intestinal epithelial cell
LN lymph nodes
LP lamina propria
MFI mean ﬂuorescence intensity
MLN mesenteric lymph nodes
OVA ovalbumin
PLN peripheral lymph nodes
PP Peyer’s patches
RA retinoic acid
RALDH retinal dehydrogenase
RAR retinoic acid receptor
SPF speciﬁc pathogen free
sPGN soluble sonicated peptidoglycan
SPL spleen
TGF transforming growth factor
TLR Toll-like receptor
TNF tumor necrosis factor
TSLP thymic stromal lymphopoietin
Treg regulatory T cell
wt wild-type
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